Last reviewed · How we verify
[14C] SIM0270 Oral Preparation — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
[14C] SIM0270 Oral Preparation ([14C] SIM0270 Oral Preparation) — Jiangsu Simcere Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| [14C] SIM0270 Oral Preparation TARGET | [14C] SIM0270 Oral Preparation | Jiangsu Simcere Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- [14C] SIM0270 Oral Preparation CI watch — RSS
- [14C] SIM0270 Oral Preparation CI watch — Atom
- [14C] SIM0270 Oral Preparation CI watch — JSON
- [14C] SIM0270 Oral Preparation alone — RSS
Cite this brief
Drug Landscape (2026). [14C] SIM0270 Oral Preparation — Competitive Intelligence Brief. https://druglandscape.com/ci/14c-sim0270-oral-preparation. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab